Form 4: Matinas BioPharma Holdings Insider Reports Stock Transaction
Insider Transaction (Form 4)
Sanitam Partners LLC reported changes in beneficial ownership of Matinas BioPharma Holdings, Inc. common stock on June 10, 2026.
Summary
- Other acquisition/disposition: disposed of 1,406 Series C Convertible Preferred Stock at $0.59 ($824) on June 10, 2026 (Direct).
- Other acquisition/disposition: disposed of 4,798,636 Warrants to Purchase Common Stock at $0.64 ($3,093,201) on June 10, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sanitam Partners LLC — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-06-10 | Other acquisition/disposition | Series C Convertible Preferred Stock | 1,406 | $1 | $824 | 0 |
| 2026-06-10 | Other acquisition/disposition | Warrants to Purchase Common Stock | 4,798,636 | $1 | $3.1M | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-06-10 | Other acquisition/disposition (1,406 shares) |
| 2026-06-10 | Other acquisition/disposition (4,798,636 shares) |
Keywords
insider transaction, Form 4, MTNB, Matinas BioPharma Holdings, Inc., neutral, Sanitam Partners LLC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.